These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16292724)

  • 21. Ziprasidone-induced Pisa syndrome after clozapine treatment.
    Ziegenbein M; Schomerus G; Kropp S
    J Neuropsychiatry Clin Neurosci; 2003; 15(4):458-9. PubMed ID: 14627778
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute dystonia after initial doses of ziprasidone: a case report.
    Yumru M; Savas HA; Selek S; Savas E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):745-7. PubMed ID: 16580766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 12,800-mg ziprasidone overdose without significant ECG changes.
    Arbuck DM
    Gen Hosp Psychiatry; 2005; 27(3):222-3. PubMed ID: 15882771
    [No Abstract]   [Full Text] [Related]  

  • 24. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A; Dwolatzky T; Lerner V
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ziprasidone-induced lupus erythematosus.
    Swensen E; Ravasia S
    Can J Psychiatry; 2004 Jun; 49(6):413-4. PubMed ID: 15283542
    [No Abstract]   [Full Text] [Related]  

  • 26. Ziprasidone and hypomania.
    Duggal HS; Singh I
    CNS Spectr; 2005 Aug; 10(8):606; author reply 606. PubMed ID: 16173129
    [No Abstract]   [Full Text] [Related]  

  • 27. Med-psych drug-drug interactions update.
    Armstrong SC; Cozza KL
    Psychosomatics; 2001; 42(5):435-7. PubMed ID: 11739913
    [No Abstract]   [Full Text] [Related]  

  • 28. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic monitoring for QT prolongation in patients treated with ziprasidone--a claims database approach.
    Lin YL; Wu YC; Tsai GF
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):842-7. PubMed ID: 19551702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Biswas AK; Zabrocki LA; Mayes KL; Morris-Kukoski CL
    J Toxicol Clin Toxicol; 2003; 41(1):79-82. PubMed ID: 12645973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
    Chung AK; Chua SE
    J Clin Psychopharmacol; 2007 Oct; 27(5):517-9. PubMed ID: 17873690
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiotoxicity associated with intentional ziprasidone and bupropion overdose.
    Biswas AK; Zabrocki LA; Mayes KL; Morris-Kukoski CL
    J Toxicol Clin Toxicol; 2003; 41(2):101-4. PubMed ID: 12733844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unintentional ingestion of ziprasidone in a 22-month-old.
    MacVane CZ; Baumann MR
    Pediatr Emerg Care; 2009 Jul; 25(7):460-2. PubMed ID: 19606003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract]   [Full Text] [Related]  

  • 37. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urticaria and angio-oedema due to ziprasidone.
    Akkaya C; Sarandol A; Aydogan K; Kirli S
    J Psychopharmacol; 2007 Jul; 21(5):550-2. PubMed ID: 17446198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    Montejo AL; Rico-Villademoros F;
    J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.